We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications.
MONTREAL and CHARLOTTE, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today announced that the Company granted equity...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1798 | -8.32407407407 | 2.16 | 2.17 | 1.92 | 665965 | 1.99632747 | CS |
4 | -0.372 | -15.8149817192 | 2.3522 | 2.3897 | 1.9 | 631430 | 2.08755675 | CS |
12 | 0.3352 | 20.376899696 | 1.645 | 2.75 | 1.61 | 553292 | 2.00416002 | CS |
26 | 0.4902 | 32.8993288591 | 1.49 | 2.75 | 1.2691 | 324786 | 1.86148773 | CS |
52 | 0.4302 | 27.7548387097 | 1.55 | 2.75 | 1.12 | 280877 | 1.78450792 | CS |
156 | -5.0498 | -71.8321479374 | 7.03 | 9.8465 | 1.12 | 240621 | 3.71178166 | CS |
260 | -19.3898 | -90.7337388863 | 21.37 | 23.245 | 1.12 | 528594 | 6.06049023 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions